229 related articles for article (PubMed ID: 32024820)
1. Reversal of CYLD phosphorylation as a novel therapeutic approach for adult T-cell leukemia/lymphoma (ATLL).
Xu X; Kalac M; Markson M; Chan M; Brody JD; Bhagat G; Ang RL; Legarda D; Justus SJ; Liu F; Li Q; Xiong H; Ting AT
Cell Death Dis; 2020 Feb; 11(2):94. PubMed ID: 32024820
[TBL] [Abstract][Full Text] [Related]
2. StIKKing it to a death kinase: IKKs prevent TNF-α-induced cell death by phosphorylating RIPK1.
Dillon CP; Balachandran S
Cytokine; 2016 Feb; 78():47-50. PubMed ID: 26630177
[TBL] [Abstract][Full Text] [Related]
3. IκB kinase promotes Nrf2 ubiquitination and degradation by phosphorylating cylindromatosis, aggravating oxidative stress injury in obesity-related nephropathy.
Chen YY; Hong H; Lei YT; Zou J; Yang YY; He LY
Mol Med; 2021 Oct; 27(1):137. PubMed ID: 34711178
[TBL] [Abstract][Full Text] [Related]
4. CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis.
Moquin DM; McQuade T; Chan FK
PLoS One; 2013; 8(10):e76841. PubMed ID: 24098568
[TBL] [Abstract][Full Text] [Related]
5. TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation.
Lafont E; Draber P; Rieser E; Reichert M; Kupka S; de Miguel D; Draberova H; von Mässenhausen A; Bhamra A; Henderson S; Wojdyla K; Chalk A; Surinova S; Linkermann A; Walczak H
Nat Cell Biol; 2018 Dec; 20(12):1389-1399. PubMed ID: 30420664
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin sensitizes cancer cells to Smac mimetic via synergistic activation of the CYLD/RIPK1/FADD/caspase-8-dependent apoptosis.
Yang C; Ran Q; Zhou Y; Liu S; Zhao C; Yu X; Zhu F; Ji Y; Du Q; Yang T; Zhang W; He S
Apoptosis; 2020 Jun; 25(5-6):441-455. PubMed ID: 32418059
[TBL] [Abstract][Full Text] [Related]
7. Impaired RIPK1 ubiquitination sensitizes mice to TNF toxicity and inflammatory cell death.
Kist M; Kőműves LG; Goncharov T; Dugger DL; Yu C; Roose-Girma M; Newton K; Webster JD; Vucic D
Cell Death Differ; 2021 Mar; 28(3):985-1000. PubMed ID: 32999468
[TBL] [Abstract][Full Text] [Related]
8. Protein Kinase-Mediated Decision Between the Life and Death.
Engin A
Adv Exp Med Biol; 2021; 1275():1-33. PubMed ID: 33539010
[TBL] [Abstract][Full Text] [Related]
9. NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling.
Dondelinger Y; Jouan-Lanhouet S; Divert T; Theatre E; Bertin J; Gough PJ; Giansanti P; Heck AJ; Dejardin E; Vandenabeele P; Bertrand MJ
Mol Cell; 2015 Oct; 60(1):63-76. PubMed ID: 26344099
[TBL] [Abstract][Full Text] [Related]
10. Immune dysregulation in SHARPIN-deficient mice is dependent on CYLD-mediated cell death.
Ang RL; Chan M; Legarda D; Sundberg JP; Sun SC; Gillespie VL; Chun N; Heeger PS; Xiong H; Lira SA; Ting AT
Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34887354
[TBL] [Abstract][Full Text] [Related]
11. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD.
Zhang M; Wu X; Lee AJ; Jin W; Chang M; Wright A; Imaizumi T; Sun SC
J Biol Chem; 2008 Jul; 283(27):18621-6. PubMed ID: 18467330
[TBL] [Abstract][Full Text] [Related]
12. Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death.
Taft J; Markson M; Legarda D; Patel R; Chan M; Malle L; Richardson A; Gruber C; Martín-Fernández M; Mancini GMS; van Laar JAM; van Pelt P; Buta S; Wokke BHA; Sabli IKD; Sancho-Shimizu V; Chavan PP; Schnappauf O; Khubchandani R; Cüceoğlu MK; Özen S; Kastner DL; Ting AT; Aksentijevich I; Hollink IHIM; Bogunovic D
Cell; 2021 Aug; 184(17):4447-4463.e20. PubMed ID: 34363755
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of RIPK1 serine 25 mediates IKK dependent control of extrinsic cell death in T cells.
Blanchett S; Dondelinger Y; Barbarulo A; Bertrand MJM; Seddon B
Front Immunol; 2022; 13():1067164. PubMed ID: 36532075
[TBL] [Abstract][Full Text] [Related]
14. Cylindromatosis Is Required for Survival of a Subset of Melanoma Cells.
La T; Jin L; Liu XY; Song ZH; Farrelly M; Feng YC; Yan XG; Zhang YY; Thorne RF; Zhang XD; Teng L
Oncol Res; 2020 Sep; 28(4):385-398. PubMed ID: 32252875
[TBL] [Abstract][Full Text] [Related]
15. Identification of TBK1 and IKKε, the non-canonical IκB kinases, as crucial pro-survival factors in HTLV-1-transformed T lymphocytes.
Zhang H; Chen L; Cai SH; Cheng H
Leuk Res; 2016 Jul; 46():37-44. PubMed ID: 27123832
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2.
Annibaldi A; Wicky John S; Vanden Berghe T; Swatek KN; Ruan J; Liccardi G; Bianchi K; Elliott PR; Choi SM; Van Coillie S; Bertin J; Wu H; Komander D; Vandenabeele P; Silke J; Meier P
Mol Cell; 2018 Feb; 69(4):566-580.e5. PubMed ID: 29452637
[TBL] [Abstract][Full Text] [Related]
17. Importance of Validating Antibodies and Small Compound Inhibitors Using Genetic Knockout Studies-T Cell Receptor-Induced CYLD Phosphorylation by IKKε/TBK1 as a Case Study.
Lork M; Kreike M; Staal J; Beyaert R
Front Cell Dev Biol; 2018; 6():40. PubMed ID: 29755980
[TBL] [Abstract][Full Text] [Related]
18. 8-Geranylumbelliferone isolated from Paramignya trimera triggers RIPK1/RIPK3-dependent programmed cell death upon TNFR1 ligation.
Piao X; Byun HS; Lee SR; Ju E; Park KA; Sohn KC; Quan KT; Lee J; Na M; Hur GM
Biochem Pharmacol; 2021 Oct; 192():114733. PubMed ID: 34411570
[TBL] [Abstract][Full Text] [Related]
19. LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway.
Hasegawa H; Yamada Y; Tsukasaki K; Mori N; Tsuruda K; Sasaki D; Usui T; Osaka A; Atogami S; Ishikawa C; Machijima Y; Sawada S; Hayashi T; Miyazaki Y; Kamihira S
Leukemia; 2011 Apr; 25(4):575-87. PubMed ID: 21242994
[TBL] [Abstract][Full Text] [Related]
20. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Chung EY; Mai Y; Shah UA; Wei Y; Ishida E; Kataoka K; Ren X; Pradhan K; Bartholdy B; Wei X; Zou Y; Zhang J; Ogawa S; Steidl U; Zang X; Verma A; Janakiram M; Ye BH
Clin Cancer Res; 2019 Jun; 25(12):3589-3601. PubMed ID: 30862694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
